Alexion stock crashed Friday after officials agreed to review Amgen's challenge to the patents covering Alexion's blockbuster drug, Soliris.
View full coverage on Google NewsAlexion Stock Crashes As Amgen Seeks To Invalidate Soliris Patents - Investor's Business Daily
Read More
Bagikan Berita Ini
Related Posts :
The treats you're feeding your dog may be making you or your family sick, CDC says - WKOW- Bill Gates goes Harry Potter talking about Steve Jobs - Quartz
- OPEC Plans Move To Seize Market Share From US Shale - OilPrice.com
- Pepsi, Delta, and Other Stocks for Investors to Watch This Week - Barron's
- Financial planner calculates retirement income without Social Security - Business Insider
0 Response to "Alexion Stock Crashes As Amgen Seeks To Invalidate Soliris Patents - Investor's Business Daily"
Post a Comment